Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|January 1, 2021
Systemic inflammation response index (SIRI) as a predictive factor for overall survival in advanced soft tissue sarcoma treated with eribulinHiroshi Kobayashi, Tomotake Okuma, Koichi Okajima, et al.Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|June 22, 2020
Pretreatment serum C-reactive protein is a significant prognostic factor in patients with soft tissue metastasesYuki Ishibashi, Hiroshi Kobayashi, Ryoko Sawada, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 7, 2018
H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological featuresNaohiro Makise, Masaya Sekimizu, Eiichi Konishi, et al.International Journal of Clinical Oncology|November 1, 2017
Neutrophil-to-lymphocyte ratio after pazopanib treatment predicts response in patients with advanced soft-tissue sarcomaHiroshi Kobayashi, Tomotake Okuma, Hiroyuki Oka, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 10, 2019
Absence of H3F3A mutation in a subset of malignant giant cell tumor of boneKen-Ichi Yoshida, Yoshiko Nakano, Mai Honda-Kitahara, et al.BMC Musculoskeletal Disorders|April 13, 2019
Predictive factors for complications after surgical treatment for schwannomas of the extremitiesToshihide Hirai, Hiroshi Kobayashi, Toru Akiyama, et al.The American Journal of Surgical Pathology|March 17, 2021
Clinicopathologic Characterization of Epithelioid Hemangioendothelioma in a Series of 62 Cases: A Proposal of Risk Stratification and Identification of a Synaptophysin-positive Aggressive SubsetTakahiro Shibayama, Naohiro Makise, Toru Motoi, et al.Cancer Management and Research|October 29, 2020
Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology GroupTomoki Nakamura, Jun Sugaya, Norifumi Naka, et al.Clinical & Experimental Metastasis|August 2, 2020
Prediction of pathological fracture in patients with lower limb bone metastasis using computed tomography imagingYusuke Shinoda, Ryoko Sawada, Yuki Ishibashi, et al.Cancer Science|June 25, 2020
Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas: A Japanese Musculoskeletal Oncology Group studyHiroshi Urakawa, Akira Kawai, Takahiro Goto, et al.Pageof 4